Blood pressure medication recalled over possibly containing cancer-causing 'impurity'
Fox News
A Lupin Pharmaceuticals Inc. blood pressure medication is being recalled by the U.S. Food and Drug Administration (FDA) for potentially containing a "probable human carcinogen."
In an Oct. 14 release, the agency said it made the assessment based on results from laboratory testing.
"As part of Lupin’s ongoing assessment, analysis revealed that certain tested API batches (but not finished product batches) were above the specification limit for the impurity, N-nitrosoirbesartan," the FDA wrote. "Although Lupin has received no reports of illness that appear to relate to this issue, the company, out of an abundance of caution, is recalling all batches of Irbesartan Tablets USP 75mg, 150mg and 300mg and Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300mg/12.5mg in the US."